Physician profile

Sam S Ahn

Vascular Surgery · Los Angeles, CA

NPI 1497783831

$21,016.31

in general payments reported to CMS, 2019-2025

43 companies · $821 in 2025

The $821 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,987.68
Honoraria$2,500.00
Consulting Fee$375.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Asahi Intecc USA, INC. $15,192.25 2022-2023 Asahi Ptca Guide Wire
Endologix LLC $845.06 2019-2025 Alto Abdominal Stent Graft System
Koya Medical, INC. $607.82 2024 Dayspring, Koya Medical
Philips North America LLC $469.86 2019-2022
Medtronic, INC. $411.43 2021-2025 Endurant Iis, Abre
Cordis US Corp. $375.00 2023
Asahi Intecc Co., Ltd. $330.26 2022-2023 Velloute, Tellus
Bard Peripheral Vascular, INC. $300.80 2021-2025 Rotarexs 6 F X 135 Cm
Catheter Precision, INC. Fka Ra Medical Systems, INC. $229.65 2019-2020
Angiodynamics, INC. $202.08 2020-2025 Auryon Laser System 100-120 Vac
Ucb, INC. $192.60 2025 Fintepla, Briviact
Smith+Nephew, INC. $176.90 2019-2022
Bolton Medical INC $169.75 2022-2024 Treo Abdominal Stent-Graft System
Boston Scientific Corporation $168.54 2021-2024 Avvigo Guidance System
Tactile Systems Technology INC $150.12 2020-2025 Flexitouch Plus, Entre Plus, Nimbl
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $126.40 2019
Novartis Pharmaceuticals Corporation $123.54 2024-2025
Janssen Pharmaceuticals, INC $113.00 2019-2022
Axogen $109.71 2024-2025 Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft
Lemaitre Vascular, INC. $89.14 2019-2023 Xenosure Biologic Patch
Veryan Medical Incorporated $68.64 2021
Silk Road Medical, INC. $47.44 2019
Pfizer INC. $47.24 2020-2021
Cardiovascular Systems INC. $41.92 2021
E.R. Squibb & Sons, L.L.C. $39.25 2022-2024 Eliquis
Resmed Corp $36.55 2022
Kerecis Limited $32.79 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Argenx US, INC. $26.50 2023 Vyvgart
Aquestive Therapeutics, INC. $26.16 2020
Hartmann USA, INC. $26.01 2022
Astrazeneca Pharmaceuticals Lp $23.76 2023
Genentech USA, INC. $23.34 2025 Xolair
Abbott Laboratories $21.13 2020
Sirtex Medical INC $19.85 2024 Sir-Spheres Microspheres
Cardiva Medical, INC. $19.80 2020
Reprise Biomedical, INC. $19.30 2022
W. L. Gore & Associates, INC. $18.89 2019
Acera Surgical, INC. $18.68 2019
Bsn Medical INC $17.57 2025
Medline Industries Lp $17.13 2024
Csl Behring $16.79 2022
Siemens Medical Solutions USA, INC. $12.94 2021
Acist Medical Systems, INC. $10.72 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sam S Ahn

$21,016.31

in general payments reported 2019-2025

Years
2019-2025
Top company
Asahi Intecc USA, INC.
Context
The $821 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/21947/sam-s-ahn

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.